Biblio
“Bilingualism and Cognitive Decline: A Story of Pride and Prejudice.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1237-1239, 2017.
, “Bimanual Gesture Imitation in Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 1, pp. 53-59, 2017.
, “Bioactive Food Abates Metabolic and Synaptic Alterations by Modulation of Gut Microbiota in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1657-1682, 2018.
, “Biochemical and Radiological Markers of Alzheimer's Disease Progression.”, J Alzheimers Dis, vol. 50, no. 3, pp. 623-44, 2016.
, “Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.”, J Alzheimers Dis, vol. 54, no. 1, pp. 307-24, 2016.
, “Biofunctionalized Silica Nanoparticles: Standards in Amyloid-β Oligomer-Based Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 79-88, 2016.
, “A Bioinformatics Approach Toward Unravelling the Synaptic Molecular Crosstalk Between Alzheimer's Disease and Diabetes.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1917-1933, 2022.
, “Biological Factors Contributing to the Response to Cognitive Training in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 1, pp. 333-345, 2018.
, “Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1113-1123, 2018.
, “Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab.”, J Alzheimers Dis, vol. 53, no. 2, pp. 535-46, 2016.
, “Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 69-78, 2017.
, “Biomarkers Differentiating Dementia with Lewy Bodies from Other Dementias: A Meta-Analysis.”, J Alzheimers Dis, vol. 50, no. 1, pp. 161-74, 2016.
, “Biomarkers for Early Diagnosis of Alzheimer's Disease in the Oldest Old: Yes or No?”, J Alzheimers Dis, vol. 58, no. 2, pp. 323-335, 2017.
, “Bipolar Disorder and Frontotemporal Dementia: An Intriguing Association.”, J Alzheimers Dis, vol. 55, no. 3, pp. 973-979, 2017.
, “Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein.”, J Alzheimers Dis, vol. 80, no. 2, pp. 813-829, 2021.
, “Blockade of the Interaction of Calcineurin with FOXO in Astrocytes Protects Against Amyloid-β-Induced Neuronal Death.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1471-8, 2016.
, “Blood Glucose Levels May Exacerbate Executive Function Deficits in Older Adults with Cognitive Impairment.”, J Alzheimers Dis, 2018.
, “Blood Inflammatory Mediators and Cognitive Decline in Alzheimer's Disease: A Two Years Longitudinal Study.”, J Alzheimers Dis, vol. 63, no. 1, pp. 87-92, 2018.
, “Blood Pressure and Hispanic/Latino Cognitive Function: Hispanic Community Health Study/Study of Latinos Results.”, J Alzheimers Dis, vol. 59, no. 1, pp. 31-42, 2017.
, “Blood Pressure and Later-Life Cognition in Hispanic and White Adults (BP-COG): A Pooled Cohort Analysis of ARIC, CARDIA, CHS, FOS, MESA, and NOMAS.”, J Alzheimers Dis, vol. 89, no. 3, pp. 1103-1117, 2022.
, “Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology.”, J Alzheimers Dis, 2015.
, “A Blood Test for Alzheimer's Disease: It's about Time or Not Ready for Prime Time?”, J Alzheimers Dis, vol. 90, no. 3, pp. 963-966, 2022.
, “A Blood Test for Alzheimer's Disease: Progress, Challenges, and Recommendations.”, J Alzheimers Dis, vol. 64, no. s1, pp. S289-S297, 2018.
, “Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance.”, J Alzheimers Dis, vol. 90, no. 3, pp. 967-974, 2022.
, “A Blood-Based, 7-Metabolite Signature for the Early Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, 2015.
,